Cargando…
A case of successful conversion from everolimus to surgical resection of a giant pancreatic neuroendocrine tumor
BACKGROUND: Although pancreatic neuroendocrine tumors generally have a far better prognosis relative to pancreatic cancer, the varied manifestations lead to treatment-related challenges. Everolimus therapy is generally recommended for patients with advanced pancreatic neuroendocrine tumors; however,...
Autores principales: | Sato, Asahi, Masui, Toshihiko, Sankoda, Nao, Nakano, Kenzo, Uchida, Yuichiro, Anazawa, Takayuki, Takaori, Kyoichi, Kawaguchi, Yoshiya, Uemoto, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519517/ https://www.ncbi.nlm.nih.gov/pubmed/28730577 http://dx.doi.org/10.1186/s40792-017-0361-8 |
Ejemplares similares
-
Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution
por: Masui, Toshihiko, et al.
Publicado: (2022) -
Current state and future evolution of pancreatic islet transplantation
por: Anazawa, Takayuki, et al.
Publicado: (2018) -
Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response
por: Yamane, Kei, et al.
Publicado: (2020) -
The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation
por: Tada, Seiichiro, et al.
Publicado: (2020) -
A subcentimeter duodenal neuroendocrine neoplasm with a liver metastasis upgraded to G3: a case report
por: Kitada, Tomoya, et al.
Publicado: (2021)